作者
Yoanna Skrobik, Matthew S Duprey, Nicholas S Hill, John W Devlin
发表日期
2018/5/1
期刊
American journal of respiratory and critical care medicine
卷号
197
期号
9
页码范围
1147-1156
出版商
American Thoracic Society
简介
Rationale: Dexmedetomidine is associated with less delirium than benzodiazepines and better sleep architecture than either benzodiazepines or propofol; its effect on delirium and sleep when administered at night to patients requiring sedation remains unclear.
Objectives: To determine if nocturnal dexmedetomidine prevents delirium and improves sleep in critically ill adults.
Methods: This two-center, double-blind, placebo-controlled trial randomized 100 delirium-free critically ill adults receiving sedatives to receive nocturnal (9:30 p.m. to 6:15 a.m.) intravenous dexmedetomidine (0.2 μg/kg/h, titrated by 0.1 μg /kg/h every 15 min until a goal Richmond Agitation and Sedation Scale score of −1 or maximum rate of 0.7 μg/kg/h was reached) or placebo until ICU discharge. During study infusions, all sedatives were halved; opioids were unchanged. Delirium was assessed using the Intensive Care Delirium Screening …
引用总数
201820192020202120222023202416495551473824
学术搜索中的文章
Y Skrobik, MS Duprey, NS Hill, JW Devlin - American journal of respiratory and critical care …, 2018